On July 13, the FDA issued an Emergency Use Authorization for the Novavax COVID-19 Vaccine, Adjuvanted. It is a two-dose series, doses given three weeks apart. It is only to be used for the primary series, not for boosters.
Novavax is a protein subunit vaccine, not an mRNA vaccine. Protein subunit COVID-19 vaccines contain pieces (proteins) of the virus that causes COVID-19; these proteins